A detailed history of Pnc Financial Services Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,741,772 shares of ABT stock, worth $533 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
4,741,772
Previous 4,767,067 0.53%
Holding current value
$533 Million
Previous $495 Million 9.14%
% of portfolio
0.35%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $2.53 Million - $2.99 Million
-25,295 Reduced 0.53%
4,741,772 $541 Million
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $20.4 Million - $22.8 Million
-202,574 Reduced 4.08%
4,767,067 $495 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $2.53 Million - $2.79 Million
23,098 Added 0.47%
4,969,641 $565 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $8.53 Million - $10.4 Million
-94,586 Reduced 1.88%
4,946,543 $544 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $4.71 Million - $5.65 Million
-49,293 Reduced 0.97%
5,041,129 $488 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $8.79 Million - $9.8 Million
-87,267 Reduced 1.69%
5,090,422 $555 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $744,272 - $876,052
-7,684 Reduced 0.15%
5,177,689 $524 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $6.02 Million - $7.07 Million
-63,356 Reduced 1.21%
5,185,373 $569 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $7.06 Million - $8.17 Million
-72,931 Reduced 1.37%
5,248,729 $508 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $9.49 Million - $11.5 Million
92,982 Added 1.78%
5,321,660 $578 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $5.34 Million - $6.51 Million
-46,818 Reduced 0.89%
5,228,678 $619 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $29.9 Million - $36.6 Million
259,019 Added 5.16%
5,275,496 $742 Million
Q3 2021

Nov 05, 2021

SELL
$116.66 - $129.06 $1.67 Million - $1.84 Million
-14,291 Reduced 0.28%
5,016,477 $593 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $467,697 - $550,547
4,421 Added 0.09%
5,030,768 $583 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $34.8 Million - $41 Million
319,644 Added 6.79%
5,026,347 $602 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $11.6 Million - $12.6 Million
-110,552 Reduced 2.29%
4,706,703 $515 Million
Q3 2020

Nov 06, 2020

BUY
$91.64 - $111.29 $6.77 Million - $8.22 Million
73,869 Added 1.56%
4,817,255 $524 Million
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $955,210 - $1.22 Million
12,475 Added 0.26%
4,743,386 $434 Million
Q1 2020

May 08, 2020

SELL
$62.82 - $91.86 $4.43 Million - $6.48 Million
-70,575 Reduced 1.47%
4,730,911 $373 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $3.13 Million - $3.48 Million
-39,852 Reduced 0.82%
4,801,486 $417 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $5.63 Million - $6.11 Million
-68,830 Reduced 1.4%
4,841,338 $405 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $8.72 Million - $10.2 Million
-119,680 Reduced 2.38%
4,910,168 $0
Q1 2019

May 10, 2019

SELL
$66.22 - $80.06 $2.14 Million - $2.59 Million
-32,345 Reduced 0.64%
5,029,848 $0
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $593,580 - $672,440
-9,054 Reduced 0.18%
5,062,193 $366 Million
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $4.15 Million - $5.01 Million
-68,254 Reduced 1.33%
5,071,247 $0
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $3.82 Million - $4.22 Million
-66,393 Reduced 1.28%
5,139,501 $0
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $21.9 Million - $24.7 Million
-389,005 Reduced 6.95%
5,205,894 $0
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $77.7 Million - $83.1 Million
-1,446,558 Reduced 20.54%
5,594,899 $0
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $338 Million - $378 Million
7,041,457
7,041,457 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.